Viewing Study NCT01463059


Ignite Creation Date: 2025-12-24 @ 3:02 PM
Ignite Modification Date: 2025-12-26 @ 8:31 PM
Study NCT ID: NCT01463059
Status: COMPLETED
Last Update Posted: 2013-03-25
First Post: 2011-10-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of Olokizumab With Rheumatoid Arthritis With Previously Failed to Anti-tumor Necrosis Factor (Anti-TNF) Therapy
Sponsor: UCB Japan Co. Ltd.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2011-10
Start Date Type: None
Primary Completion Date: 2013-02
Primary Completion Date Type: ACTUAL
Completion Date: 2013-02
Completion Date Type: ACTUAL
First Submit Date: 2011-10-27
First Submit QC Date: None
Study First Post Date: 2011-11-01
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: 2013-03-25
Disp First Post Date Type: ESTIMATED
Last Update Submit Date: 2013-03-19
Last Update Post Date: 2013-03-25
Last Update Post Date Type: ESTIMATED